{"id":"standard-tb-treatment","safety":{"commonSideEffects":[{"rate":"1-5","effect":"Hepatotoxicity"},{"rate":"1-3","effect":"Peripheral neuropathy"},{"rate":"5-10","effect":"Gastrointestinal disturbance"},{"rate":"1-5","effect":"Rash"},{"rate":"null","effect":"Hyperuricemia"},{"rate":"<1","effect":"Optic neuritis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"The standard first-line TB regimen typically includes isoniazid (inhibits mycolic acid synthesis in the bacterial cell wall), rifampicin (inhibits bacterial RNA polymerase), pyrazinamide (disrupts bacterial metabolism), and ethambutol (inhibits arabinosyl transferases involved in cell wall synthesis). This multi-drug approach targets multiple pathways simultaneously to prevent resistance and achieve bactericidal activity.","oneSentence":"Standard TB treatment uses a combination of antimicrobial agents that inhibit bacterial cell wall synthesis and protein synthesis to kill or suppress Mycobacterium tuberculosis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:36:27.208Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tuberculosis (drug-susceptible)"},{"name":"Latent tuberculosis infection (preventive therapy)"}]},"trialDetails":[{"nctId":"NCT07164742","phase":"NA","title":"Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-03-18","conditions":"TB - Tuberculosis, TB, TB Infection","enrollment":690},{"nctId":"NCT04466488","phase":"NA","title":"Prevent TB: Choice Architecture for TPT Delivery","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-09-15","conditions":"HIV/AIDS, Tuberculosis","enrollment":50798},{"nctId":"NCT04930744","phase":"PHASE2","title":"Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-08-26","conditions":"Tuberculosis, Pulmonary Tuberculosis, HIV Coinfection","enrollment":112},{"nctId":"NCT06593080","phase":"NA","title":"The DECIDE-TB Trial; Validation of Treatment Decision Algorithms for Childhood Tuberculosis","status":"RECRUITING","sponsor":"Chishala Chabala","startDate":"2024-06-01","conditions":"Tuberculosis, Child Health, HIV","enrollment":30240},{"nctId":"NCT02129244","phase":"NA","title":"A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2014-10","conditions":"MDR-TB, HIV","enrollment":3600},{"nctId":"NCT07477119","phase":"PHASE4","title":"Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment","status":"NOT_YET_RECRUITING","sponsor":"Marco Schiuma","startDate":"2026-03","conditions":"Linezolid, Tuberculosis Multi Drug Resistant Active, Therapeutic Drug Monitoring (TDM)","enrollment":150},{"nctId":"NCT07472348","phase":"","title":"Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors","status":"NOT_YET_RECRUITING","sponsor":"ASST Fatebenefratelli Sacco","startDate":"2026-05-30","conditions":"Tuberculosis Infection, Tuberculosis Infection, Latent","enrollment":220},{"nctId":"NCT07467252","phase":"PHASE2","title":"AIPH-TB: AI-Optimised Pyrazinamide-Hydroxychloroquine vs Standard RIPE for Drug-Sensitive Pulmonary Tuberculosis - A Phase II RCT","status":"NOT_YET_RECRUITING","sponsor":"Ministry of Health, Saudi Arabia","startDate":"2026-09","conditions":"Pulmonary Tuberculosis","enrollment":200},{"nctId":"NCT04230395","phase":"NA","title":"Alcohol Reduction Among People With TB and HIV in India","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-09-22","conditions":"Tuberculosis, HIV","enrollment":450},{"nctId":"NCT07453472","phase":"PHASE3","title":"Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia","status":"NOT_YET_RECRUITING","sponsor":"Dr. Shalini Gupta","startDate":"2026-04","conditions":"Oral Leukoplakia","enrollment":166},{"nctId":"NCT02354014","phase":"PHASE2","title":"Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2016-05-03","conditions":"Tuberculosis, Multidrug-Resistant","enrollment":60},{"nctId":"NCT07440160","phase":"NA","title":"Digitally Facilitated, Integrated Community and Facility-Based Interventions: The HEART-TB Trial Protocol","status":"ACTIVE_NOT_RECRUITING","sponsor":"Arba Minch University","startDate":"2025-07-01","conditions":"Tuberculosis","enrollment":278},{"nctId":"NCT07436104","phase":"PHASE4","title":"Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.","status":"COMPLETED","sponsor":"MAHAN Trust","startDate":"2004-01-01","conditions":"Hypertension (HTN), Diarrhea, Pneumonia","enrollment":72564},{"nctId":"NCT03512249","phase":"PHASE2","title":"Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence","status":"COMPLETED","sponsor":"International AIDS Vaccine Initiative","startDate":"2019-01-31","conditions":"Tuberculosis, Pulmonary","enrollment":831},{"nctId":"NCT05556746","phase":"PHASE2","title":"Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-11-24","conditions":"Tuberculosis, Pulmonary, HIV","enrollment":94},{"nctId":"NCT07419568","phase":"NA","title":"Burden of Tuberculosis Among Pregnant and Postpartum Women in Guinea-Bissau","status":"NOT_YET_RECRUITING","sponsor":"Aarhus University Hospital","startDate":"2026-02","conditions":"Tuberculosis (TB), Tuberculosis Infection, Latent, Pregnancy","enrollment":720},{"nctId":"NCT07387601","phase":"NA","title":"Effect of Peer-led Educational Intervention on Treatment Outcomes Among Adults With Drug-susceptible Pulmonary Tuberculosis in South Omo and Ari Zone, Southern Ethiopia","status":"NOT_YET_RECRUITING","sponsor":"Bahirdar University","startDate":"2026-02-24","conditions":"to Assess Effect of Peer-led Education","enrollment":250},{"nctId":"NCT06153069","phase":"PHASE4","title":"Asymptomatic TB With Innovative Modified Short-course Regimens","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2025-11-21","conditions":"Tuberculosis","enrollment":426},{"nctId":"NCT06498414","phase":"PHASE2, PHASE3","title":"Shorter and Safer Treatment Regimens for Latent TB","status":"RECRUITING","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2025-06-10","conditions":"Tuberculosis Infection, Latent","enrollment":1800},{"nctId":"NCT03089983","phase":"NA","title":"Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings","status":"COMPLETED","sponsor":"Yale University","startDate":"2017-08-21","conditions":"Opioid Dependence, Addiction, HIV/AIDS","enrollment":316},{"nctId":"NCT05842161","phase":"NA","title":"South Africa Smoking Cessation and Engagement in HIV/TB Care Care","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-03-12","conditions":"HIV Infections, Tuberculosis, Smoking Cessation","enrollment":86},{"nctId":"NCT04298905","phase":"NA","title":"Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-10","conditions":"Adherence, Patient, TB, HIV/AIDS","enrollment":62},{"nctId":"NCT06318416","phase":"PHASE1","title":"Precision Rifampin Trial for Personalized Dosing","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-10-01","conditions":"Tuberculosis","enrollment":200},{"nctId":"NCT05553236","phase":"NA","title":"Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-08-01","conditions":"Drug-resistant Tuberculosis, HIV Coinfection, Cost-Benefit Analysis","enrollment":2500},{"nctId":"NCT07303699","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2026-01-03","conditions":"Pulmonary Tuberculosis (TB)","enrollment":80},{"nctId":"NCT06814041","phase":"NA","title":"Pilot RCT and Interview Study on an HIV Chatbot in Nigeria","status":"ACTIVE_NOT_RECRUITING","sponsor":"Christoph Pimmer","startDate":"2025-04-14","conditions":"HIV","enrollment":314},{"nctId":"NCT03500172","phase":"NA","title":"HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2018-06-22","conditions":"HIV-1 Virologic Response","enrollment":1391},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT07162194","phase":"NA","title":"MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial","status":"RECRUITING","sponsor":"University of Southern California","startDate":"2025-09-19","conditions":"Prostate Carcinoma","enrollment":130},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT07313995","phase":"NA","title":"Digital Health Intervention to Improve TPT Uptake","status":"NOT_YET_RECRUITING","sponsor":"Arba Minch University","startDate":"2026-01-15","conditions":"Tuberculosis, Pulmonary","enrollment":304},{"nctId":"NCT06214910","phase":"NA","title":"ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa","status":"COMPLETED","sponsor":"University of Washington","startDate":"2024-02-20","conditions":"Tuberculosis, HIV I Infection","enrollment":301},{"nctId":"NCT07303361","phase":"NA","title":"Effect of Active Mandibular Techniques and Specific Cranio-cervical Therapeutic Exercise in Patients With Temporomandibular Disorders and Bruxism (AMaCe-TB)","status":"COMPLETED","sponsor":"Instituto de Investigación Biomédica de Salamanca","startDate":"2023-11-22","conditions":"Temporomandibular Disorder (TMD)","enrollment":60},{"nctId":"NCT04738812","phase":"PHASE3","title":"Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2022-04-21","conditions":"Tuberculosis, HIV-1-infection, Immuno-Deficiency","enrollment":1330},{"nctId":"NCT04919239","phase":"PHASE2","title":"Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB)","status":"COMPLETED","sponsor":"Archivel Farma S.L.","startDate":"2021-09-22","conditions":"Tuberculosis, Pulmonary","enrollment":140},{"nctId":"NCT04240990","phase":"NA","title":"Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2019-11-04","conditions":"Tuberculosis, Severe Acute Malnutrition","enrollment":603},{"nctId":"NCT07271225","phase":"NA","title":"Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and Vomiting","status":"RECRUITING","sponsor":"Indonesia University","startDate":"2025-11-05","conditions":"Tuberculosis, Pulmonary","enrollment":58},{"nctId":"NCT05630872","phase":"PHASE2","title":"Pharmacokinetics and Safety of Double-dose Dolutegravir When Used With Rifapentine for HIV-associated Tuberculosis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-02-13","conditions":"HIV-associated Tuberculosis","enrollment":30},{"nctId":"NCT03831906","phase":"NA","title":"Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2019-03-20","conditions":"Tuberculosis, Severe Pneumonia, Covid19","enrollment":2570},{"nctId":"NCT07263269","phase":"NA","title":"Comparing Dumping Symptoms and Quality of Life 6 Months After Sleeve Gastrectomy With or Without Transit Bipartition in Adults With Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mina Kamal Gergis Erian","startDate":"2024-04-06","conditions":"Obesity, Morbid Obesity, Dumping Syndrome","enrollment":200},{"nctId":"NCT05069688","phase":"PHASE1","title":"Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2023-07-07","conditions":"Pediatric HIV Infection, Tuberculosis Infection","enrollment":20},{"nctId":"NCT06905522","phase":"PHASE3","title":"A PAN-USR TB Multi-Center Trial","status":"RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-06-18","conditions":"Pulmonary Tuberculosis","enrollment":610},{"nctId":"NCT06084715","phase":"","title":"The INSTITUT Study Tuberculosis Nutritional Support","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2023-09-07","conditions":"Tuberculosis, Pulmonary, Undernutrition","enrollment":769},{"nctId":"NCT07227779","phase":"PHASE2","title":"B-PaLMZ for TB Meningitis","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-02-15","conditions":"Tuberculous Meningitis","enrollment":240},{"nctId":"NCT05342064","phase":"NA","title":"Closing -TB GAPs - for People Living With HIV: TB Guidance for Adaptable Patient-Centered Service","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2023-07-11","conditions":"Tuberculosis, HIV Coinfection, Tuberculosis Infection","enrollment":6500},{"nctId":"NCT05671718","phase":"NA","title":"Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-09-04","conditions":"Drug Resistant Tuberculosis","enrollment":2944},{"nctId":"NCT06114628","phase":"PHASE2","title":"Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB","status":"RECRUITING","sponsor":"University College, London","startDate":"2024-01-09","conditions":"Pulmonary Tuberculosis","enrollment":2500},{"nctId":"NCT04734652","phase":"PHASE2","title":"INSTI's For The Management of HIV-associated TB","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2022-02-18","conditions":"HIV/AIDS, Tuberculosis, Pulmonary","enrollment":122},{"nctId":"NCT07207239","phase":"NA","title":"Effect of Theta-burst rTMS Therapy on the Clinical and Cognitive Symptoms of Patients With Therapy Resistant Depression and Response Prediction With Neuroimaging Methods.","status":"ENROLLING_BY_INVITATION","sponsor":"Semmelweis University","startDate":"2025-06-13","conditions":"Transcranial Magnetic Stimulation, Repetitive, Depression - Major Depressive Disorder","enrollment":54},{"nctId":"NCT05220163","phase":"NA","title":"Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2022-02-23","conditions":"Tuberculosis, COVID-19, HIV Infections","enrollment":26200},{"nctId":"NCT06199921","phase":"PHASE2","title":"ATORvastatin in Pulmonary TUBerculosis","status":"RECRUITING","sponsor":"Obafemi Awolowo University Teaching Hospital","startDate":"2024-01-03","conditions":"Pulmonary Tuberculosis, Tuberculosis, Koch's Disease","enrollment":440},{"nctId":"NCT06497465","phase":"PHASE3","title":"Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-09-18","conditions":"Tuberculosis, HIV","enrollment":150},{"nctId":"NCT06667609","phase":"","title":"Validity and Reliability of the Mastitis Symptom Severity Assessment Methods (M-Score and BISSI) in Non-Lactational Mastitis","status":"RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2024-08-28","conditions":"Granulomatous Mastitis, Mastitis Chronic","enrollment":300},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT07160361","phase":"PHASE4","title":"Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2025-10-01","conditions":"Carcinoma, Hepatocellular","enrollment":56},{"nctId":"NCT06737380","phase":"PHASE1","title":"UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients","status":"RECRUITING","sponsor":"LiveKidney.Bio","startDate":"2025-01-07","conditions":"SLE, Lupus, Systemic Lupus Erthematosus","enrollment":10},{"nctId":"NCT06796647","phase":"","title":"ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-03-19","conditions":"Tuberculosis (TB)","enrollment":100},{"nctId":"NCT05473520","phase":"PHASE3","title":"Doxycycline Host-directed Therapy to Improve Lung Function and Decrease Tissue Destruction in Pulmonary Tuberculosis","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2023-05-24","conditions":"Tuberculosis, Acute Coronary Syndrome, Pulmonary Hypertension (Diagnosis)","enrollment":150},{"nctId":"NCT07136987","phase":"PHASE3","title":"A Trial of 2 Disease-Modifying Drugs (Metformin and N-acetylcysteine ) to Promote TB Lung Function Recovery","status":"NOT_YET_RECRUITING","sponsor":"Open Source Pharma Foundation","startDate":"2026-01","conditions":"Tuberculosis","enrollment":1104},{"nctId":"NCT07118696","phase":"PHASE3","title":"Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease","status":"NOT_YET_RECRUITING","sponsor":"Hamilton Health Sciences Corporation","startDate":"2026-02-01","conditions":"Pulmonary TB","enrollment":1000},{"nctId":"NCT07117370","phase":"NA","title":"Assessing the Feasibility of Coach Mpilo for Men With TB and HIV","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2024-06-01","conditions":"Tuberculosis, HIV","enrollment":240},{"nctId":"NCT04466293","phase":"NA","title":"Choice Architecture Based TB Preventive Therapy Prescribing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2021-03-29","conditions":"HIV/AIDS, Tuberculosis","enrollment":57},{"nctId":"NCT04527874","phase":"NA","title":"Viral Load Triggered ART Care in Lesotho","status":"COMPLETED","sponsor":"Swiss Tropical & Public Health Institute","startDate":"2020-10-14","conditions":"HIV Infections","enrollment":5809},{"nctId":"NCT05417620","phase":"NA","title":"Le Kip Kip: A Campaign to Change Social Norms and Build Sustainable Demand for PrEP Among Women in South Africa","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2022-10-01","conditions":"Pre-exposure Prophylaxis, HIV Infections","enrollment":601},{"nctId":"NCT07076225","phase":"PHASE3","title":"Ultra-Short Regimen for Elderly DS-TB","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-07-25","conditions":"Pulmonary Tuberculosis","enrollment":300},{"nctId":"NCT05091580","phase":"NA","title":"Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2023-03-24","conditions":"Depression, Tuberculosis","enrollment":1410},{"nctId":"NCT07069387","phase":"NA","title":"Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence","status":"RECRUITING","sponsor":"University of Malaya","startDate":"2025-04-07","conditions":"Tuberculosis (TB)","enrollment":160},{"nctId":"NCT07067528","phase":"NA","title":"The Feasibility and Acceptability of a Post-tuberculosis Lung Disease Diagnostic Algorithm in Uganda.","status":"NOT_YET_RECRUITING","sponsor":"Mbarara University of Science and Technology","startDate":"2026-09-01","conditions":"Post Pulmonary Tuberculosis, Post-Tuberculous Bronchiectasis","enrollment":80},{"nctId":"NCT06739915","phase":"NA","title":"Targeted Universal TB Testing With Simultaneous TPT Prescribing Among People Living With HIV in South Africa","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2024-05-28","conditions":"HIV/AIDS, Tuberculosis","enrollment":414},{"nctId":"NCT03315962","phase":"NA","title":"Simplified Isoniazid Preventive Therapy Strategy to Reduce TB Burden","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2017-11-15","conditions":"Tuberculosis, HIV/AIDS","enrollment":163},{"nctId":"NCT06274060","phase":"NA","title":"Project Phakama: Testing Support Strategies to Empower Young Women on PrEP in South Africa","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-04-16","conditions":"Pre-exposure Prophylaxis, HIV Infections","enrollment":304},{"nctId":"NCT03988933","phase":"PHASE2","title":"2R2: Higher Dose Rifampin for 2 Months vs Standard Dose Rifampin for Latent TB.","status":"COMPLETED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2019-09-20","conditions":"Latent Tuberculosis","enrollment":1368},{"nctId":"NCT05633056","phase":"NA","title":"An Adaptive Randomized Controlled Trial","status":"RECRUITING","sponsor":"Columbia University","startDate":"2023-03-07","conditions":"Multi Drug Resistant Tuberculosis, HIV Infections","enrollment":360},{"nctId":"NCT06909799","phase":"NA","title":"A Confirmatory Trial of Adjunctive NAC to Prevent Post Tuberculosis Lung Disease","status":"RECRUITING","sponsor":"The Aurum Institute NPC","startDate":"2025-04-28","conditions":"Tuberculosis (TB)","enrollment":242},{"nctId":"NCT04260477","phase":"PHASE3","title":"Novel Triple-dose Tuberculosis Retreatment Regimen","status":"RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2021-03-01","conditions":"Multidrug-resistant Tuberculosis, Pulmonary Tuberculosis, Tuberculosis","enrollment":370},{"nctId":"NCT05221502","phase":"PHASE2","title":"Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-04-12","conditions":"Pulmonary TB","enrollment":122},{"nctId":"NCT06916962","phase":"NA","title":"Examining Psycho-Socioeconomic Linkages in TB Care: The UPLIFT Trial","status":"RECRUITING","sponsor":"Freundeskreis Für Internationale Tuberkulosehilfe e.V","startDate":"2025-03-14","conditions":"Tuberculosis (TB)","enrollment":1324},{"nctId":"NCT05081401","phase":"PHASE3","title":"Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2022-05-23","conditions":"Multidrug Resistant Tuberculosis, Rifampicin Resistant Tuberculosis, Pre-XDR-TB","enrollment":1050},{"nctId":"NCT05452616","phase":"NA","title":"Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2022-10-19","conditions":"Human Immunodeficiency Virus (HIV) Infection","enrollment":610},{"nctId":"NCT04568954","phase":"NA","title":"TB-CAPT CORE Truenat Trial","status":"COMPLETED","sponsor":"Foundation for Innovative New Diagnostics, Switzerland","startDate":"2022-08-28","conditions":"Tuberculosis, Diagnoses Disease","enrollment":3987},{"nctId":"NCT06883643","phase":"NA","title":"Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2022-02-04","conditions":"Focus of the Study is to Evaluate DSD Models for Both TB Treatment and TPT Usiing Key Performance Indicators","enrollment":3318},{"nctId":"NCT06191692","phase":"PHASE3","title":"1HP Versus 3HR in the Treatment of Tuberculosis Infection in Vietnam","status":"NOT_YET_RECRUITING","sponsor":"Freundeskreis Für Internationale Tuberkulosehilfe e.V","startDate":"2025-08-01","conditions":"Tuberculosis Infection","enrollment":350},{"nctId":"NCT05426837","phase":"NA","title":"Combatting Social Isolation in Older Adults","status":"COMPLETED","sponsor":"Florida State University","startDate":"2022-07-30","conditions":"Loneliness, Social Isolation","enrollment":70},{"nctId":"NCT05971602","phase":"PHASE2","title":"Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis","status":"TERMINATED","sponsor":"Gates Medical Research Institute","startDate":"2023-07-26","conditions":"Pulmonary Tuberculosis","enrollment":93},{"nctId":"NCT06811792","phase":"","title":"Intrathecal Therapy for Adult Tuberculous Meningitis: Impact on Clinical Outcomes","status":"COMPLETED","sponsor":"Beijing Chest Hospital","startDate":"2010-01-01","conditions":"Tuberculous Meningitis","enrollment":837},{"nctId":"NCT05005637","phase":"PHASE2","title":"The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA","status":"COMPLETED","sponsor":"Fakultas Kedokteran Universitas Indonesia","startDate":"2021-08-27","conditions":"Tuberculous Uveitis","enrollment":78},{"nctId":"NCT06281834","phase":"PHASE1","title":"Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2024-11-15","conditions":"Pediatric HIV Infection, Latent Tuberculosis","enrollment":25},{"nctId":"NCT06744179","phase":"","title":"Post TB Sequelae Study","status":"ENROLLING_BY_INVITATION","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2024-07-07","conditions":"Tuberculosis, Pulmonary","enrollment":600},{"nctId":"NCT06719193","phase":"PHASE2, PHASE3","title":"DeMONSTRATE-TB Study in Ethiopia","status":"RECRUITING","sponsor":"Management Sciences for Health","startDate":"2023-02-27","conditions":"Reducing Tuberculosis Incidence","enrollment":131438},{"nctId":"NCT03702738","phase":"PHASE2","title":"Adjunctive NAC in Adult Patients With Pulmonary Tuberculosis","status":"COMPLETED","sponsor":"The Aurum Institute NPC","startDate":"2019-03-01","conditions":"Tuberculosis, Pulmonary","enrollment":110},{"nctId":"NCT05964842","phase":"NA","title":"Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda","status":"COMPLETED","sponsor":"Makerere University","startDate":"2023-08-14","conditions":"Tuberculosis","enrollment":2355},{"nctId":"NCT01380080","phase":"PHASE4","title":"REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2011-10","conditions":"HIV Infection","enrollment":851},{"nctId":"NCT06613919","phase":"PHASE4","title":"Six-months Versus Nine-months ATT for Ocular TB","status":"COMPLETED","sponsor":"L.V. Prasad Eye Institute","startDate":"2020-01-01","conditions":"Tuberculosis (TB), Uveitis, Retinal Vasculitis","enrollment":58},{"nctId":"NCT02808507","phase":"NA","title":"Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2016-07-18","conditions":"Tuberculosis","enrollment":4852},{"nctId":"NCT04062201","phase":"PHASE3","title":"Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care","status":"COMPLETED","sponsor":"Wits Health Consortium (Pty) Ltd","startDate":"2019-08-22","conditions":"Tuberculosis, Pre-XDR-TB, Extensively Drug-Resistant Tuberculosis","enrollment":402},{"nctId":"NCT06539455","phase":"","title":"Analysis of Liver Injury Risk Factors in a Multiethnic Population Treated With Antituberculosis Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Stefania Cheli","startDate":"2024-07-05","conditions":"Tuberculosis Infection","enrollment":127},{"nctId":"NCT05122624","phase":"NA","title":"A Clinical Risk Score for Early Management of TB in Uganda","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2021-11-10","conditions":"Tuberculosis, Pulmonary","enrollment":3332},{"nctId":"NCT04303104","phase":"NA","title":"Xpert Active Case-finding Trial 3 (XACT-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-03-26","conditions":"Tuberculosis","enrollment":3394},{"nctId":"NCT04856644","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2020-01-01","conditions":"Tuberculosis, Pulmonary","enrollment":333},{"nctId":"NCT05443178","phase":"PHASE1","title":"Safety and Tolerability of Chlorquine in Addition to Anti-tuberculosis Therapy","status":"RECRUITING","sponsor":"University of Zurich","startDate":"2022-01-04","conditions":"Tuberculosis Infection","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":69,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Control arm"],"phase":"phase_3","status":"active","brandName":"Standard TB treatment","genericName":"Standard TB treatment","companyName":"The Aurum Institute NPC","companyId":"the-aurum-institute-npc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard TB treatment uses a combination of antimicrobial agents that inhibit bacterial cell wall synthesis and protein synthesis to kill or suppress Mycobacterium tuberculosis. Used for Tuberculosis (drug-susceptible), Latent tuberculosis infection (preventive therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}